ArticleProceedings of the National Academy of Sciences of the United States of America2018

From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection.

Shalley N Kudalkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.